Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 9.

Weiser, B; Philpott, S; Klimkait, T; Burger, H; Kitchen, C; Bürgisser, P; Gorgievski, M; Perrin, L; Piffaretti, J C; Ledergerber, B (2008). HIV-1 coreceptor usage and CXCR4-specific viral load predict clinical disease progression during combination antiretroviral therapy. AIDS, 22(4):469-479.

Yerly, S; von Wyl, V; Ledergerber, B; Böni, J; Schüpbach, J; Bürgisser, P; Klimkait, T; Rickenbach, M; Kaiser, L; Günthard, H F; Perrin, L (2007). Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS, 21(16):2223-2229.

von Wyl, V; Yerly, S; Böni, J; Bürgisser, P; Klimkait, T; Battegay, M; Furrer, H; Telenti, A; Hirschel, B; Vernazza, P L; Bernasconi, E; Rickenbach, M; Perrin, L; Ledergerber, B; Günthard, H F; Swiss HIV Cohort Study (2007). Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types. Archives of Internal Medicine, 167(16):1782-1790.

Hoen, B; Cooper, D A; Lampe, F C; Perrin, L; Clumeck, N; Phillips, A N; Goh, L-E; Lindback, S; Sereni, D; Gazzard, B; Montaner, J; Stellbrink, H-J; Lazzarin, A; Ponscarme, D; Staszewski, S; Mathiesen, L; Smith, D; Finlayson, R; Weber, R; Wegmann, L; Janossy, G; Kinloch-de Loes, S (2007). Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005. Clinical Infectious Diseases, 45(3):381-390.

Schüpbach, J; Günthard, H F; Joos, B; Fischer, M B; Böni, J; Tomasik, Z; Yerly, S; Perrin, L; Battegay, M; Furrer, H; Vernazza, P; Bernasconi, E; Hirschel, B (2005). HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. JAIDS Journal of Acquired Immune Deficiency Syndromes, 40(3):250-256.

Kaufmann, G R; Furrer, H; Ledergerber, B; Perrin, L; Opravil, M; Vernazza, P; Cavassini, M; Bernasconi, E; Rickenbach, M; Hirschel, B; Battegay, M (2005). Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical Infectious Diseases, 41(3):361-372.

Böni, J; Bisset, L R; Burckhardt, J J; Joller-Jemelka, H I; Bürgisser, P; Perrin, L; Gorgievski, M; Erb, P; Fierz, W; Piffaretti, J C; Schüpbach, J (2004). Prevalence of human T-cell leukemia virus types I and II in Switzerland. Journal of Medical Virology, 72(2):328-337.

Böni, J; Pyra, H; Gebhardt, M; Perrin, L; Bürgisser, P; Matter, L; Fierz, W; Erb, P; Piffaretti, J C; Minder, E; Grob, P; Burckhardt, J J; Zwahlen, M; Schüpbach, J (1999). High frequency of non-B subtypes in newly diagnosed HIV-1 infections in Switzerland. JAIDS Journal of Acquired Immune Deficiency Syndromes, 22(2):174-179.

Yerly, S; Rutschmann, O T; Opravil, M; Marchal, F; Hirschel, B; Perrin, L (1999). Cell‐Associated HIV‐1 RNA in Blood as Indicator of Virus Load in Lymph Nodes. Journal of Infectious Diseases, 180(3):850-853.

This list was generated on Wed Jan 16 19:25:30 2019 CET.